Apply Now

Do you have a rectal cancer?

The CG-100 study is evaluating a new investigational treatment that may reduce the rate of diverting stoma and its related complications.

Qualified participants include:
  • Adults between 22 and 65 years of age.
  • Those who are undergoing colorectal surgery with a mesorectal excision and are planned to have a protecting diverting stoma as part of the operation.
  • Additional criteria apply

Those who qualify will receive treatment from a board-certified surgeon.

Please enter your Full Legal Name:

All information provided is confidential and will not be given or sold to any other agency without prior consent.
By clicking the “SUBMIT” button, I understand and agree to the Privacy Policy and Terms of Use. I agree to receive communication from the Colospan Contact Center regarding my inquiries. I understand that any services and information provided to me are supplied as a professional courtesy and are intended to assist me in forming my own conclusions and making my own decisions. I understand that any services and information provided to me are not to be construed as medical advice nor should it be used for diagnostic purposes. I Understand that with any medical related question I should also consult local medical sources.

We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Privacy Policy. To agree to our use of cookies click Accept.